Search for stocks /

Cryogenic OGS Ltd H2 FY26 FY26 – 30% EBITDA Margin Dream vs ₹331 Cr Valuation Reality: Skid Maker or Silent Compounder?


1. At a Glance – The ₹331 Crore Question Nobody Is Asking Loud Enough

There are companies that shout growth. And then there are companies that quietly bolt together industrial systems, win tenders, ship skids to oil terminals… and somehow end up with 30% EBITDA margins in a capital goods business.

Cryogenic OGS Ltd belongs firmly in the second category.

At first glance, it looks deceptively small — ₹331 crore market cap, ₹40.8 crore annual revenue, ₹9.26 crore PAT. That is the kind of company most investors scroll past without a second thought. But pause for a moment.

This is not just a fabrication shop.

This is a company supplying mission-critical metering and fluid systems to oil terminals — where failure is not just inconvenient, it is financially catastrophic. And that changes everything.

Because when failure costs crores per hour, buyers stop bargaining like vegetable vendors.

Now layer on this:

  • EBITDA margins touching ~30% (as per management commentary)
  • PAT growth of ~52% TTM
  • ROCE ~26.9%, ROE ~22.1%
  • Near-zero debt history (management claim for years)

And suddenly, this “small” company starts looking like a very deliberate business model.

But then comes the uncomfortable part.

  • Top 10 customers contribute ~89% revenue
  • Majority business routed via EPC contractors, not direct clients
  • India contributes ~99% revenue

This is not diversification. This is concentration risk dressed as stability.

And yet, the company is evolving.

Management is attempting a strategic transformation — moving from:

“₹30 value fabrication player → ₹100 full system integrator”

If they succeed, margins stay high and revenue scales.

If they fail, working capital balloons and execution risk explodes.

So here’s the real question:

Is Cryogenic OGS a hidden industrial compounder… or just a well-run small vendor riding a temporary order cycle?

Let’s go deeper.


2. Introduction – The Quiet Operator in a Loud Industry

Cryogenic OGS has been around since 1997. That alone tells you something — this is not a startup story. This is a survival story.

Originally a fabrication-focused business, it pivoted into oil & gas applications around 2008–09, entering a sector where:

  • Qualification cycles are long
  • Failure tolerance is zero
  • Replacement cycles stretch up to 10 years

In other words, once you enter, you don’t get replaced easily.

The company manufactures systems like:

  • Metering skids
  • Filtration systems
  • Pressure reduction units
  • Dosing and blending equipment

These are not glamour products. Nobody writes LinkedIn posts about them.

But they sit at the heart of fuel logistics — ensuring accurate measurement, safe transfer, and regulatory compliance.

Now here’s where it gets interesting.

Cryogenic doesn’t usually sell directly to oil companies like IOCL or BPCL. Instead, it operates through EPC players:

  • Emerson
  • Honeywell
  • Yokogawa

These giants win the contracts. Cryogenic becomes the approved vendor inside that ecosystem.

Management itself admitted:

“Complete contract will be taken by EPC companies… we are an approved supplier…”

Which means:

  • Demand is stable (because EPC pipeline exists)
  • Pricing power is limited (because EPC sits in the middle)

This duality defines the business.

Now ask yourself:

Would you rather own the EPC giant… or the high-margin niche supplier behind it?


3. Business Model – WTF Do They Even Do?

Let’s simplify this brutally.

Cryogenic OGS builds industrial “plug-and-play systems” for fluids.

Think of

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!